Clearpoint Historical Cash Flow
| CLPT Stock | USD 11.18 0.07 0.63% |
Analysis of Clearpoint Neuro cash flow over time is an excellent tool to project Clearpoint Neuro future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 6.4 M or Begin Period Cash Flow of 29 M as it is a great indicator of Clearpoint Neuro ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Clearpoint Neuro latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Clearpoint Neuro is a good buy for the upcoming year.
Clearpoint |
About Clearpoint Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Clearpoint balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Clearpoint's non-liquid assets can be easily converted into cash.
Clearpoint Neuro Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Clearpoint Neuro to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Clearpoint Neuro operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Change Receivables
The difference in the amount of accounts receivable from one accounting period to the next. A positive number indicates an increase in receivables, while a negative number indicates a decrease.Most accounts from Clearpoint Neuro's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Clearpoint Neuro current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clearpoint Neuro. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.At this time, Clearpoint Neuro's Change To Netincome is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 1.9 M in 2024, whereas Change In Working Capital is likely to drop (373.8 K) in 2024.
Clearpoint Neuro cash flow statement Correlations
Click cells to compare fundamentals
Clearpoint Neuro Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Clearpoint Neuro cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (1.0M) | (25K) | (1.7M) | (4.4M) | 1.2M | 1.3M | |
| Change In Cash | 2.6M | 14.4M | 34.0M | (26.5M) | (4.5M) | (4.3M) | |
| Stock Based Compensation | 799.1K | 1.1M | 2.1M | 4.1M | 6.1M | 6.4M | |
| Free Cash Flow | (3.0M) | (8.3M) | (12.9M) | (17.3M) | (14.8M) | (14.0M) | |
| Change In Working Capital | 911.3K | (2.7M) | (1.7M) | (4.3M) | (356K) | (373.8K) | |
| Begin Period Cash Flow | 3.1M | 5.7M | 20.1M | 54.1M | 27.6M | 29.0M | |
| Other Cashflows From Financing Activities | 313.8K | 25.2M | 47.5M | 745K | 506K | 671.6K | |
| Depreciation | 250.6K | 553K | 692K | 777K | 1.5M | 1.5M | |
| Other Non Cash Items | 729.3K | 893K | 425K | (346K) | (18K) | (17.1K) | |
| Capital Expenditures | 160.2K | 482K | 168K | 1.1M | 1.1M | 1.1M | |
| Total Cash From Operating Activities | (2.8M) | (7.8M) | (12.7M) | (16.2M) | (13.7M) | (13.0M) | |
| Change To Account Receivables | 144.0K | (791K) | 627K | (211K) | (1.8M) | (1.7M) | |
| Net Income | (5.5M) | (6.8M) | (14.4M) | (16.4M) | (22.1M) | (21.0M) | |
| Total Cash From Financing Activities | 5.6M | 22.7M | 46.9M | 409K | 296K | 281.2K | |
| End Period Cash Flow | 5.7M | 20.1M | 54.1M | 27.6M | 23.1M | 13.2M | |
| Sale Purchase Of Stock | 7.8M | 24.6M | (599K) | (336K) | (210K) | (199.5K) | |
| Total Cashflows From Investing Activities | (160K) | (482K) | (168K) | (10.7M) | (9.7M) | (9.2M) | |
| Investments | (160.2K) | (482K) | (168K) | (9.6M) | 20.9M | 21.9M | |
| Change To Operating Activities | (238K) | (950K) | (762K) | (1.8M) | (1.6M) | (1.5M) | |
| Change To Netincome | 799K | 197K | 2.6M | 4.0M | 4.6M | 4.8M | |
| Change To Liabilities | 2.0M | (896K) | 1.5M | 1.6M | 1.8M | 1.9M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Clearpoint Stock Analysis
When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.